Advertisement
Advertisement
U.S. markets open in 9 hours 28 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Fresenius SE & Co. KGaA (FRE.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
24.57+0.33 (+1.36%)
At close: 05:35PM CEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close24.24
Open24.32
Bid24.52 x N/A
Ask24.53 x N/A
Day's Range24.27 - 24.90
52 Week Range23.40 - 46.73
Volume1,403,055
Avg. Volume1,310,609
Market Cap13.839B
Beta (5Y Monthly)1.13
PE Ratio (TTM)8.06
EPS (TTM)3.05
Earnings DateNov 01, 2022
Forward Dividend & Yield0.92 (3.80%)
Ex-Dividend DateMay 16, 2022
1y Target Est39.81
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for FRE.DE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Moody's

      Fresenius Finance Ireland II Plc -- Moody's affirms Fresenius SE's Baa3 rating; outlook stable

      Rating Action: Moody's affirms Fresenius SE's Baa3 rating; outlook stableGlobal Credit Research - 15 Aug 2022Frankfurt am Main, August 15, 2022 -- Moody's Investors Service ("Moody's") has today affirmed Fresenius SE & Co. KGaA's (FSE or the company) Baa3 long-term issuer rating. During the period of subdued operating performance, which will likely last until end of 2023, Moody's expects FSE will remain fully committed to its investment grade rating by prioritizing its public commitment to the 3-3.5x net leverage range over capital allocation to M&A and shareholders' distribution. The rating as of today is weakly positioned.

    • Moody's

      Fresenius Medical Care US Finance III, Inc. -- Moody's affirms Fresenius Medical Care's Baa3 rating; outlook stable

      Rating Action: Moody's affirms Fresenius Medical Care's Baa3 rating; outlook stableGlobal Credit Research - 15 Aug 2022Frankfurt am Main, August 15, 2022 -- Moody's Investors Service ("Moody's") has today affirmed Fresenius Medical Care AG & Co. KGaA's (FMC or the company) Baa3 long-term issuer rating. The outlook remains stable.A full list of affected ratings can be found at the end of this press release.RATINGS RATIONALEToday's rating affirmation with stable outlook reflects Moody's expectations that current operating headwinds are mostly temporary. During this period of subdued operating performance, which will likely last until end of 2023, Moody's expects FMC will remain fully committed to its investment grade rating by prioritizing its public commitment to the 3-3.5x net leverage range over capital allocation to M&A and shareholders' distribution.

    Advertisement
    Advertisement